BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Operating Income (2022 - 2026)

BullFrog AI Holdings' (BFRG) quarterly Operating Income came in at -$1.4 million in Q2 2026, up 3.44% on a YoY basis from -$1.4 million in Q2 2025, and up 5.31% quarter-over-quarter from -$1.5 million in Q4 2025.

Analysis

BullFrog AI Holdings (BFRG) Operating Income (2022 - 2026) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Operating Income for 5 consecutive years, with -$1.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Income rose 3.44% year-over-year to -$1.4 million; the trailing twelve-month figure through Jun 2026 stood at -$6.0 million (up 16.27% YoY), and the FY2025 full-year result was -$6.6 million, up 8.87% from the prior year.
  • Operating Income rose to -$1.4 million in Q2 2026 per BFRG's latest filing, from -$1.5 million in the prior quarter.
  • Across five years, Operating Income topped out at -$550251.0 in Q1 2022 and bottomed at -$2.1 million in Q1 2025.
  • Historically, Operating Income has averaged -$1.4 million across 5 years, with a median of -$1.5 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Operating Income sank 129.1% in 2023, then increased 15.27% in 2025.
  • Over 5 years, Operating Income stood at -$583043.0 in 2022, then tumbled by 129.1% to -$1.3 million in 2023, then plunged by 32.42% to -$1.8 million in 2024, then increased by 15.27% to -$1.5 million in 2025, then climbed by 5.31% to -$1.4 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$1.4 million, -$1.5 million, and -$1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 493.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 231.44 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -644.50 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -1.55 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00 -1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.42 Mn
Dec 31, 2025 -1.50 Mn
Sep 30, 2025 -1.57 Mn
Jun 30, 2025 -1.47 Mn
Mar 31, 2025 -2.06 Mn
Dec 31, 2024 -1.77 Mn
Sep 30, 2024 -1.82 Mn
Jun 30, 2024 -1.68 Mn
Mar 31, 2024 -1.97 Mn
Dec 31, 2023 -1.34 Mn
Sep 30, 2023 -1.30 Mn
Jun 30, 2023 -1.54 Mn
Mar 31, 2023 -1.19 Mn
Dec 31, 2022 -583,043.00
Sep 30, 2022 -640,552.00
Jun 30, 2022 -681,955.00
Mar 31, 2022 -550,251.00